An Israeli biotech has developed an investigational, proprietary protein oral delivery (POD™) technology in the development of oral vaccines that are now only available via…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.